Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Aug;29(4):479-482.
doi: 10.5021/ad.2017.29.4.479. Epub 2017 Jun 21.

Three Cases of Autoimmune Progesterone Dermatitis

Affiliations
Case Reports

Three Cases of Autoimmune Progesterone Dermatitis

Hye Rin You et al. Ann Dermatol. 2017 Aug.

Retraction in

Abstract

Autoimmune progesterone dermatitis is a rare cyclic premenstrual reaction to progesterone produced during the luteal phase of the menstrual cycle. The clinical symptoms of autoimmune progesterone dermatitis overlap with other forms of dermatosis such as erythema multiforme, eczema, fixed drug eruption, urticaria, and angioedema. We experienced 3 cases of autoimmune progesterone dermatitis. All patients had a recurrent history of monthly skin eruptions. Skin lesions normally began a few days before menstruation and resolved a few days later. Patients were confirmed to have autoimmune progesterone dermatitis by the results of the progesterone intradermal test. All three patients had different clinical findings such as erythema annulare centrifugum, urticaria, contact dermatitis, and rosacea. Because patients presented with variable clinical manifestations, they could have been easily misdiagnosed. The patients were treated with oral contraceptive, antihistamine and steroids for symptom control. We propose that dermatologists should consider autoimmune progesterone dermatitis in cases of recurrent cyclic skin eruptions in female patients. Further, if this condition is suspected, thorough history taking including that on menstrual cycle and intradermal progesterone test should be performed.

Keywords: Autoimmune progesterone dermatitis; Menstrual cycle; Progesterone.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. (A, B) Clearly marked erythematous patches with edema on both cheeks (patient 1). (C) Intradermal progesterone test was performed in patient 1. Within 3 minutes, a 2-cm-sized erythema at the progesterone injection site. After 20 minutes, erythema remained.
Fig. 2
Fig. 2. (A, B) Pruritic erythematous patches with edema on the chest and back (patient 2). (C) Histological examination of the chest lesion showed patchy infiltration of lymphocytes and a few eosinophils (H&E; ×40, inset: ×400). (D) Positive intradermal progesterone test in patient 2. After 30 minutes, 1.5-cm sized erythema and wheal is distinctly seen (left). After 48 hours, erythema persists at the progesterone injection site right). P: progesterone, S: saline.
Fig. 3
Fig. 3. (A, B) Pruritic and stingy erythematous polycyclic patches on the trunk (patient 3). (C) A 0.5-cm-sized wheal is observed after 30 minutes. Further, gyrated patches on the face, neck, hands appeared after 24 hours.

Similar articles

Cited by

References

    1. Herzberg AJ, Strohmeyer CR, Cirillo-Hyland VA. Autoimmune progesterone dermatitis. J Am Acad Dermatol. 1995;32:333–338. - PubMed
    1. Walling HW, Scupham RK. Autoimmune progesterone dermatitis. Case report with histologic overlap of erythema multiforme and urticaria. Int J Dermatol. 2008;47:380–382. - PubMed
    1. Wojnarowska F, Greaves MW, Peachey RD, Drury PL, Besser GM. Progesterone-induced erythema multiforme. J R Soc Med. 1985;78:407–408. - PMC - PubMed
    1. Asai J, Katoh N, Nakano M, Wada M, Kishimoto S. Case of autoimmune progesterone dermatitis presenting as fixed drug eruption. J Dermatol. 2009;36:643–645. - PubMed
    1. Halevy S, Cohen AD, Lunenfeld E, Grossman N. Autoimmune progesterone dermatitis manifested as erythema annulare centrifugum: confirmation of progesterone sensitivity by in vitro interferon-gamma release. J Am Acad Dermatol. 2002;47:311–313. - PubMed

LinkOut - more resources